TapewireFind a company

person · Reporting owner

Dudum Andrew

Disclosed activity across 1 company

Tapewire entity
18974
SEC CIK
0001837796

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Director · Chief Executive Officer · 10% ownerAugust 25, 2026August 28, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date August 25, 2026 · Filed August 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT463,289 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 463,289

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Legacy 2021 Trust103,406 Reported balance After 2026-08-27 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Class A Common StockSEC Table I · non-derivativeDirect1,033,177 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,033,177

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015573,202 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 573,202

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2025 GRAT dated 5-27-202542,993 Reported balance Holding disclosure · report date 2026-08-25 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 42,993

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Community Property Trust470,457 Reported balance Holding disclosure · report date 2026-08-25 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 470,457

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022791,117 Reported balance Holding disclosure · report date 2026-08-25 · row 8 Holding and transaction disclosures are not merged.
1 source row

Row 8 · Balance 791,117

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-20212,214,769 Reported balance Holding disclosure · report date 2026-08-25 · row 9 Holding and transaction disclosures are not merged.
1 source row

Row 9 · Balance 2,214,769

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family 2021 Trust3,004,071 Reported balance Holding disclosure · report date 2026-08-25 · row 10 Holding and transaction disclosures are not merged.
1 source row

Row 10 · Balance 3,004,071

Filing footnotes · ownership attribution and instrument terms

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 16, 2025 Filed Oct 20, 2025 20:42 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 8,423 $63.46 $534,513.47
Disclosure

SEC source: 0001773751-25-000342 · wk-form4_1760992920.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 47,524

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.31 - $63.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 16, 2025 Filed Oct 20, 2025 20:42 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 39,111 $62.70 $2,452,247.97
Disclosure

SEC source: 0001773751-25-000342 · wk-form4_1760992920.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 55,947

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.215 - $63.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 16, 2025 Filed Oct 20, 2025 20:42 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $62.65 $174,923.83
Disclosure

SEC source: 0001773751-25-000342 · wk-form4_1760992920.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,523

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 20:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 65,110 $50.57 $3,292,905.70
Disclosure

SEC source: 0001773751-25-000311 · wk-form4_1758313669.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,315

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.06 - $50.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 108,334 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 28

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 539,729

Underlying: Class A Common Stock · 108,334 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F17 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 27

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,006

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F16 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,810 $53.81 $958,381.03
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,425

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F11 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.62 - $54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 32,190 $53.03 $1,706,980.98
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 12

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,235

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $52.62 - $53.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,729 $53.81 $954,008.13
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 11

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,425

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.62 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 23,938 $53.08 $1,270,518.93
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 10

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 228,154

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $52.62 - $53.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 16,667 $53.79 $896,534.60
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 252,092

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.37 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 108,334 $2.43 $263,251.62
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,001 $53.79 $914,517.79
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,425

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.38 - $54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 18,882 $53.85 $1,016,769.27
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 95,058

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.435 - 54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 28,652 $52.90 $1,515,556.14
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 113,940

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $52.45 - $53.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $54.21 $151,358.51
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,425

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.01 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 19,150 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 26

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,106

Underlying: Class A Common Stock · 19,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 74,529 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 25

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 745,299

Underlying: Class A Common Stock · 74,529 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,447 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 24

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 212,679

Underlying: Class A Common Stock · 35,447 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F13 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F13 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,242 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · derivative · entry 23

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,484

Underlying: Class A Common Stock · 35,242 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F12 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F12 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 90,672 $53.96 $4,892,661.12
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,217

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 23:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 164,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-25-000301 · wk-form4_1758151482.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 108,334 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 648,063

Underlying: Class A Common Stock · 108,334 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F11 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,007

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F10 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 16,667 $44.92 $748,696.64
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,521

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.65 - $45.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 50,000 $45.04 $2,251,980.00
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,188

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.69 - $45.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 41,667 $45.11 $1,879,644.20
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,188

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.68 - $45.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 108,334 $2.43 $263,251.62
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 197,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,001 $45.14 $767,379.24
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,521

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.95 - $45.39. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $44.97 $125,542.28
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,521

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.85 - $45.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 47,534 $45.05 $2,141,492.26
Disclosure

SEC source: 0001773751-25-000280 · wk-form4_1755720875.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 142,592

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.76 - $45.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 07, 2025 Filed Aug 11, 2025 21:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 660,000 $50.58 $33,384,120.00
Disclosure

SEC source: 0001773751-25-000273 · wk-form4_1754946444.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021

Disclosed balance after: 2,214,769

F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.25 - $51.125. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · derivative · entry 22

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 756,397

Underlying: Class A Common Stock · 50,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 41,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · derivative · entry 21

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 806,397

Underlying: Class A Common Stock · 41,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · derivative · entry 20

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 848,064

Underlying: Class A Common Stock · 16,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,008

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 50,000 $49.60 $2,479,935.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,313

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.07 - $50.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 50,000 $2.43 $121,500.00
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,313

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 41,667 $49.56 $2,064,845.69
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,313

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.09 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 41,667 $2.43 $101,250.81
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 16,667 $49.41 $823,578.14
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,313

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $49.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 16,667 $2.43 $40,500.81
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,001 $49.43 $840,277.83
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,313

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:12 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000237 · wk-form4_1753301565.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
July 16, 2025 Filed Jul 18, 2025 20:29 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 46,076 $50.24 $2,314,720.01
Disclosure

SEC source: 0001773751-25-000235 · wk-form4_1752870546.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 190,126

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.80 - $50.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 16, 2025 Filed Jul 18, 2025 20:29 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,458 $50.82 $74,097.46
Disclosure

SEC source: 0001773751-25-000235 · wk-form4_1752870546.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 236,202

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.79 - $50.89. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 16, 2025 Filed Jul 18, 2025 20:29 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $50.58 $141,216.57
Disclosure

SEC source: 0001773751-25-000235 · wk-form4_1752870546.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,313

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.47 - $50.745. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 49,165 $59.45 $2,922,706.84
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 12

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,105

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.01 - $59.75. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.